期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

器质性心脏病心房颤动患者的药物治疗 被引量：1

Drug therapy of atrial fibrillation with organic heart disease
下载PDF
导出
摘要 心房颤动(房颤)是临床常见的心律失常之一,致残、致死率高。房颤的治疗策略包括抗凝预防血栓栓塞、转复和维持窦性心律、心室率控制,药物治疗是房颤治疗的基础,但器质性心脏病合并房颤的处理有其特殊性,本文对器质性心脏病合并房颤的药物治疗予以综述。 Atrial fibrillation（AF）is one of the most common types of arrhythmia with high disability rate and mortality rate in clinical practice.Treatment strategies of AF include anticoagulation to prevent thromboembolism,conversion and sinus rhythm maintenance and ventricular rate control.However,the process of atrial fibrillation with organic heart disease has its particularity.This article reviews the medication treatment for AF with organic heart disease.
作者 齐书英 袁晓红
机构地区 白求恩国际和平医院心血管内科 石家庄市裕华区妇幼保健站
出处 《临床荟萃》 CAS 2016年第1期27-29,33,共4页 Clinical Focus
关键词 心房颤动 冠心病 药物疗法 atrial fibrillation coronary disease drug therapy
分类号 R541.75 [医药卫生—心血管疾病]
  • 相关文献

参考文献28

  • 1胡大一,孙艺红.心房颤动的流行病学和治疗现状[J].中华全科医师杂志,2006,5(1):5-7. 被引量：85
  • 2Wong CX, Lau DH, Sanders P. Atrial fibrillation epidemic and hospitalizations: how to turn the rising tide [J ]. Circulation, 2014,129(23) :2361-2363.
  • 3Lip GY, Brechin CM, Lane DA. The global burden of atrial fibrillation and stroke:a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe[J]. Chest,2012,142(6) : 1489-1498.
  • 4Romero I, Nedios S, Kriatselis C. Diagnosis and management of atrial fibrillation: an overview[J]. Cardiovasc Ther, 2014, 32(5) : 242-252.
  • 5Calkins H, Kuck KH, Cappato R, et al. 2012HRS/EHRA/ ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design [J]. Europace,2012,33(2) : 171-257.
  • 6Reddy VY, Sievert H, Halperin J, et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial [J]. JAMA,2014,312(19) : 1988-1998.
  • 7Pedersen OD, Abildstrom SZ, Ottesen MM, et al. Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction[J]. Eur Heart J,2006,27(3) :290-295.
  • 8Ruiz-Nodar JM, Marin F, Rolden V, et al. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score? [J]. Circ Cardiovasc Interv, 2012,5(4) : 459-466.
  • 9Dewilde WJ, Oirbans T, Verheugt FW, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial[J]. Lancet, 2013,381 (9872) : 1107-1115.
  • 10抗血小板治疗中国专家共识[J].中华心血管病杂志,2013,41(3):183-194. 被引量：245

二级参考文献59

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量：1401
  • 2韩雅玲,王守力,李毅,荆全民,马颖艳,王祖禄,王冬梅,栾波,王效增.急性冠状动脉综合征患者冠状动脉支架术前高负荷量氯吡格雷预治疗近期疗效[J].中国介入心脏病学杂志,2005,13(1):9-12. 被引量：53
  • 3Jeffrey S. Berger,Maria C. Roncaglioni,Fausto Avanzini,Ierta Pangrazzi,Gianni Tognoni,David L. Brown,崔艳丽（译）,赵秀丽（校）.阿斯匹林在男性和女性心血管事件一级预防中的应用——随机对照试验性别特异性汇总分析[J].美国医学会杂志（中文版）,2006,25(5):275-282. 被引量：40
  • 4Eric L Eisenstein, DBA,Kevin J. Anstrom, PhD,David F. Kong, MD,Linda K. Shaw, MS,Robert H. Tuttle, MSPH,Daniel B. Mark, MD, MPH,Judith M. Kramer, MD, MS,Robert A. Harrington, MD,David B. Matchar, MD,David E. Kandzari, MD 1,Eric D. Peterson, MD, MPH,Kevin A. Schulman, MD,Robert M. Califf, MD,李呈亿（译）,David E. Kandzari, MD.氯吡格雷的使用与药物洗脱支架植入后远期临床结果[J].美国医学会杂志（中文版）,2007,26(3):131-139. 被引量：59
  • 5Pstay BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation, 1997,96:2455-2461.
  • 6Kannel WB, Wolf PA Benjamin EJ, et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol ,1998,82:2N-9N.
  • 7Jouven X, Desnos M, Guerot C, et al. Idiopathic atrial fibrillation as a risk factor for mortality. The Paris Prospective Study Ⅰ. Eur Heart J, 1999,20:896-899.
  • 8Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med, 2002,347:1825-1833.
  • 9Hagens VE, Ranchor AV, Van Sonderen E,et al. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol,2004,43:241-247.
  • 10Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation,2001,104:2118-2150.

共引文献352

同被引文献16

引证文献1

临床荟萃
2016年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部